Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3974610012 | Product containing only eptinezumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3974611011 | Eptinezumab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2820151000001114 | Eptinezumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2820161000001112 | Eptinezumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Eptinezumab | Is a | Product containing eptinezumab (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Eptinezumab | Plays role | Antimigraine therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Eptinezumab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Eptinezumab | Has active ingredient | Eptinezumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Eptinezumab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only eptinezumab in parenteral dose form (medicinal product form) | Is a | True | Eptinezumab | Inferred relationship | Existential restriction modifier | |
| Eptinezumab 100mg/1ml solution for infusion vials | Is a | True | Eptinezumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR